Cargando…
The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, there is no effective therapeutic approach for treating SARS-CoV-2 infections. MicroRNAs (miRNAs) have been recognized to target the viral genome directly or indirectly, thereby in...
Autores principales: | Hu, Jiulue, Stojanović, Jelena, Yasamineh, Saman, Yasamineh, Pooneh, Karuppannan, Sathish Kumar, Hussain Dowlath, Mohammed Junaid, Serati-Nouri, Hamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286877/ https://www.ncbi.nlm.nih.gov/pubmed/34278528 http://dx.doi.org/10.1007/s00705-021-05152-5 |
Ejemplares similares
-
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
por: Yasamineh, Saman, et al.
Publicado: (2022) -
The roles of different microRNAs in the regulation of cholesterol in viral hepatitis
por: Meng, Xuan, et al.
Publicado: (2023) -
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
por: Oveili, Elham, et al.
Publicado: (2023) -
Correction: The roles of different microRNAs in the regulation of cholesterol in viral hepatitis
por: Meng, Xuan, et al.
Publicado: (2023) -
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
por: Yasamineh, Saman, et al.
Publicado: (2022)